The immunomodulatory effects of probiotics on respiratory viral infections: A hint for COVID-19 treatment?
Respiratory virus infections are among the most prevalent diseases in humans and contribute to morbidity and mortality in all age groups. Moreover, since they can evolve fast and cross the species barrier, some of these viruses, such as influenza A and coronaviruses, have sometimes caused epidemics...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12460
- Acceso en línea:
- https://doi.org/10.1016/j.micpath.2020.104452
http://hdl.handle.net/20.500.12010/12460
- Palabra clave:
- COVID-19
SARS-CoV-2
Probiotics
Immunomodulatory
Respiratory virus
Influenza
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido